Incidence, prevalence, and mortality estimates for chronic atrial fibrillation in Turkish adults;Türk halkinda kronik atriyal fibrilasyon insidansi, prevalansi ve mortalitesine ilişkin tahminler

Turk Kardiyoloji Dernegi Arsivi

Volumn 36, Issue 4, 2008, Pages 214-222

  Uyarel, Hüseyin ^a,f   Onat, Altan ^b,c   Yüksel, Hüsniye ^c   Can, Günay ^c   Ordu, Serkan ^d   Dursunoǧlu, Dursun ^e  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Turkish Society of Cardiology   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Yogun Bak m Section   (Turkey)

^e PAMUKKALE UNIVERSITY   (Turkey)

^f Cumhuriyet Mah   (Turkey)

Author keywords

Atrial fibrillation epidemiology; Cohort studies; Incidence; Prevalence; Sex distribution; Turkey epidemiology

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; AGING; ARTICLE; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INCIDENCE; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; TURKEY (REPUBLIC);

ADULT; AGED; AGING; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TURKEY;

EID: 55849114432     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Feinberg WM, Cornell ES, Nightingale SD, Pearce LA, Tracy RP, Hart RG, et al. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Stroke 1997;28:1101-6.
2. Friberg J, Buch P, Scharling H, Gadsbphioll N, Jensen GB. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 2003;14:666-72.
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5.
4. Flegel KM, Shipley MJ, Rose G. Risk of stroke in nonrheumatic atrial fibrillation. Lancet 1987;1:526-9.
5. Friberg J, Scharling H, Gadsboll N, Jensen GB. Sexspecific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). Am J Cardiol 2003; 92:1419-23.
6. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA 1985;254:3449-53.
7. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987;147:1561-4.
8. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27:949-53.
9. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52.
10. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/ Paisley study. Am J Med 2002;113:359-64.
11. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-22.
12. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;32:695-703.
13. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978;28:973-7.
14. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
15. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2006;48;854-906.
16. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-91.
17. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108:3006-10.
18. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292:2471-7.
19. Coromilas J. Obesity and atrial fibrillation: is one epidemic feeding the other? JAMA 2004;292:2519-20.
20. Frost L, Hüne LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med 2005;118:489-95.
21. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001;37:371-8.
22. Onat A, TEKHARF taramalarinin yöntemi ve kohortlari. In: Onat A, editör. TEKHARF Türk halkinin kalp saǧliǧi - Gizemine çözüm, evrensel tibba katki. Istanbul: Argos/Cortex İletişim; 2007. s. 8-20.
23. Hense HW, Stieber J. Blutdruck-Messkurs. Eine Einführung in die Blutdruckmessung mit einem Quecksilber-Sphygmomanometer für die Anwendung in der täglichen Praxis. Heidelberg: GSF-MEDIS Institut; 1988.
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
25. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003;26:3160-7.
26. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2007; 191:182-90.
27. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. 2nd ed. Geneva: WHO: 1982. p. 124-7.
28. T.C. Başbakanlik Türkiye Istatistik Kurumu (TÜİK). Internet erişimi: www.tuik.gov.tr.
29. Wen-Hang QI; Society of Cardiology, Chinese Medical Association. Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China. Int J Cardiol 2005;105:283-7.
30. Umetani K, Kodama Y, Nakamura T, Mende A, Kitta Y, Kawabata K, et al. High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome. Cire J 2007;71:252-5.
31. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25.
32. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-41.
33. Ruigomez A, Johansson S, Wallander MA, Rodriguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002; 55:358-63.
34. Lip GY, Bawden L, Hodson R, Rutland E, Snatchfold J, Beevers DG. Atrial fibrillation amongst the Indo-Asian general practice population. The West Birmingham Atrial Fibrillation Project. Int J Cardiol 1998;65:187-92.
35. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96:3542-8.
36. Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 2004;110:2287-92.